Garrison Michael David 4

What Happened

Michael Garrison, EVP & President, Medical Essentials & Biopharma at Becton Dickinson & Co. (BDX), sold 1,100 shares in an open-market/private sale on June 10, 2026. The shares were disposed at $151.48 each for total proceeds of $166,628. This was a sale (disposition), not a purchase.

Key Details

• Transaction date and price: 2026-06-10 — 1,100 shares at $151.48 per share (total $166,628).
• Transaction type: Sale (code S) — open market or private sale.
• Plan/authorization: Reported as executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on Feb 18, 2026.
• Footnote: Direct holdings were adjusted in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp., affecting previously reported unvested time‑vested RSUs (see F1).
• Shares owned after transaction: Not disclosed in the provided filing excerpt.
• Filing timeliness: Form 4 filed 2026-06-11 for a 2026-06-10 transaction (filed next day; appears timely).

Context

Sales under a 10b5-1 plan are prearranged and typically executed according to a schedule or set conditions, so they may not reflect the insider’s current view of the company. The footnote indicates an administrative adjustment to reported holdings tied to a business combination and unvested RSUs, which can change reported share counts without reflecting new purchases or sales.